Transradial versus transfemoral access for mechanical thrombectomy in acute ischemic stroke: A retrospective cohort study

医学 溶栓 冲程(发动机) 队列 回顾性队列研究 闭塞 导管 内科学 外科 心肌梗塞 机械工程 工程类
作者
Leonard H. Verhey,Andres Restrepo Orozco,Marion Oliver,Leah Lyons,Andrea P. Sewell,Jenny P-C Tsai,Paul Mazaris,Muhib Khan,Justin Singer
出处
期刊:Journal of stroke and cerebrovascular diseases [Elsevier]
卷期号:32 (10): 107282-107282 被引量:5
标识
DOI:10.1016/j.jstrokecerebrovasdis.2023.107282
摘要

The objective of this study was to compare procedural and clinical outcomes in patients with acute ischemic stroke (AIS) treated via transradial access (TRA) mechanical thrombectomy (MT) versus conventional transfemoral access (TFA).We performed a retrospective analysis of consecutive patients with AIS treated with TRA versus TFA MT at our tertiary comprehensive stroke center. Access choice was individualized based on occlusion site, aortic and arch anatomy. Outcomes were extracted from our institutional stroke registry and included procedural time, Thrombolysis in Cerebral Infarction (TICI) reperfusion score, NIHSS, 90-day mRS and 90-day mortality. Comparisons were performed using Student t-Test and Fischer's exact test as appropriate.175 mechanical thrombectomies were performed during the study interval; 39 (22%) were performed via TRA and 136 (79%) TFA. Access to reperfusion time was 36.3 ± 24.5 minutes in the TRA group and 21.9 ± 17.6 in the TFA group (p<0.001). The proportion of patients with a TICI reperfusion score of 2b or 3 was similar in both groups (TRA: 34 (87%) vs. TFA: 121 (89%) p=0.559. The median 90-day mRS was similar between both groups (p=0.170), as was the 90-day mortality (p = 0.509).While TFA is faster in our cohort, TFA and TRA are both safe and effective for MT in acute ischemic stroke. While TFA remains mainstay, TRA can be valuable in variant anatomy despite its technical limitations. Individualizing access based on advanced imaging and patient factors may improve practice; however, updates in catheter and access technology are necessary to optimize outcomes with TRA.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
果汁完成签到,获得积分10
刚刚
NexusExplorer应助Zoe采纳,获得10
刚刚
MADKAI发布了新的文献求助10
1秒前
1秒前
领导范儿应助junzilan采纳,获得10
2秒前
打打应助激动的一手采纳,获得10
2秒前
酷波er应助艺玲采纳,获得10
3秒前
longtengfei发布了新的文献求助10
3秒前
4秒前
4秒前
ZL发布了新的文献求助10
6秒前
luca发布了新的文献求助10
6秒前
ruby发布了新的文献求助10
6秒前
沉静的颦发布了新的文献求助10
7秒前
7秒前
cjy完成签到,获得积分10
7秒前
7秒前
8秒前
Zoe完成签到,获得积分10
8秒前
8秒前
8秒前
任性完成签到,获得积分10
8秒前
an发布了新的文献求助10
9秒前
9秒前
领导范儿应助袅袅采纳,获得10
9秒前
若狂完成签到,获得积分10
9秒前
Gyy完成签到,获得积分10
10秒前
10秒前
10秒前
上官若男应助hu970采纳,获得10
10秒前
11秒前
妮儿发布了新的文献求助10
12秒前
12秒前
Aile。完成签到,获得积分10
12秒前
12秒前
霹雳游侠完成签到,获得积分10
13秒前
hjj发布了新的文献求助10
15秒前
gg完成签到,获得积分10
15秒前
狂野觅云发布了新的文献求助10
15秒前
坚强的广山应助iRan采纳,获得200
15秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527699
求助须知:如何正确求助?哪些是违规求助? 3107752
关于积分的说明 9286499
捐赠科研通 2805513
什么是DOI,文献DOI怎么找? 1539954
邀请新用户注册赠送积分活动 716878
科研通“疑难数据库(出版商)”最低求助积分说明 709759